REGENERON PHARMACEUTICALS, INC. Diversified Active

CIK: 0000872589 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 7, 2025

Total Value ($000): $1,094,640 (100.0% shares, 0.0% debt)

Holdings (6)

ALNY Alnylam Pharmaceuticals, Inc. 95.5%

Value ($000) $1,045,822 Shares 4,444,445 Est. Cost $262.99 Unrealized 0.0%

NTLA Intellia Therapeutics, Inc. 3.9%

Value ($000) $43,177 Shares 3,702,995 Est. Cost $15.61 Unrealized 0.0%

— 2seventy bio, Inc. 0.3%

Value ($000) $3,689 Shares 1,254,827 Est. Cost $2.94 Unrealized —

— Adicet Bio, Inc. 0.1%

Value ($000) $931 Shares 968,183 Est. Cost $0.96 Unrealized —

— Adverum Biotechnologies, Inc. 0.1%

Value ($000) $845 Shares 180,909 Est. Cost $4.67 Unrealized —

— bluebird bio, Inc. 0.0%

Value ($000) $175 Shares 21,000 Est. Cost $8.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	4,444,445	$1,045,822	95.5%	$262.99	0.0%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$43,177	3.9%	$15.61	0.0%	Common Stock	45826J105
—	2seventy bio, Inc.	1,254,827	$3,689	0.3%	$2.94	—	Common Stock	901384107
—	Adicet Bio, Inc.	968,183	$931	0.1%	$0.96	—	Common Stock	007002108
—	Adverum Biotechnologies, Inc.	180,909	$845	0.1%	$4.67	—	Common Stock	00773U207
—	bluebird bio, Inc.	21,000	$175	0.0%	$8.34	—	Common Stock	09609G209